During the past decade, Complesso Integrato Columbus conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complesso Integrato Columbus" #1 sponsor was "Celgene" with 4 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Actelion" with 1 trials sponsored, "Amgen" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

According to Clinical.Site data, the most researched conditions in "Complesso Integrato Columbus" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Complex Perianal Fistula" (1 trials) and "Digital Ulcers" (1 trials). Many other conditions were trialed in "Complesso Integrato Columbus" in a lesser frequency.

Most popular intervention types in "Complesso Integrato Columbus" are "Drug" (10 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "GED-0301" (2 trials), "RPC1063" (2 trials), "UTTR1147A" (2 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Complesso Integrato Columbus" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Complesso Integrato Columbus". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Complesso Integrato Columbus, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Complesso Integrato Columbus, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".